AdaptHealth raised 2026 revenue guidance after a major strategic partner rollout, but Q1 showed the cost of scale: elevated labor, negative free cash flow and a balance sheet that still needs refinancing execution.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-15 · Issuer identity, CIK, Nasdaq listing and current AHCO ticker cross-check.SEC APIAdaptHealth SEC submissions APIRetrieved 2026-05-15 · Filing chronology and latest filing status.SEC XBRL APISEC companyfacts APIRetrieved 2026-05-15 · XBRL-derived financial cross-checks.Annual reportFiscal 2025 Form 10-K2026-02-24 · Business description, segment model, revenue recognition, payor mix, debt, goodwill, litigation and risk factors.Earnings releaseFiscal 2025 results exhibit2026-02-24 · Fiscal 2025 revenue, adjusted EBITDA, free cash flow, goodwill impairment, strategic contract and initial 2026 guidance.Quarterly reportQ1 2026 Form 10-Q2026-05-05 · Quarterly financials, balance sheet, acquisitions tied to capitation transition, debt, risk factors and liquidity context.Earnings releaseQ1 2026 results exhibit2026-05-05 · Latest operating update, strategic partner rollout, labor expense, organic revenue growth, cash flow and raised revenue guidance.Refinancing releaseApril 2026 credit facility exhibit2026-04-13 · Senior secured credit facility, maturity extension, delayed draw term loan and planned 2028 senior note redemption.Proxy statement2026 proxy statement2026-04-28 · Annual meeting, board, executive compensation, incentive metrics, ownership and governance context.